CA-San Francisco, Our client is the industry's only company exclusively focused on driving clinical trial performance at the site level, offering assistance and advocacy to research centers - directly and through their[...]
Baxter International has announced the preliminary results of a Phase I/II clinical trial, in which subcutaneous infusion of Gammagard Liquid with Enhanze technology enabled administration of a full monthly dose via a single site to patients with primary immunodeficiency.[...]
Roy Poses wrote at "Hacking an ICD" that:An ICD is a device whose correct operation is critical for the health and safety of patients in whom it is implanted. One would think that the managers responsible for the design of such devices would have pushed to make sure that the [...]
The Food and Drug Administration announced plans Friday to place regulators in China, pending approval from the Chinese government. The agency said the State Department had approved a plan to establish eight full-time, permanent FDA positions at U.S.[...]
John Lechleiter, who is about to be elevated to ceo, wrote e-mail in March 2003 to other Lilly execs that appears to have encouraged the drugmaker to promote its antipsychotic for an unapproved use, The New York Times reports. His remarks were sent after he traveled to Cincinnati to watch [...]
John C. Lechleiter, who is about to become Eli Lilly’s top executive, appears to have encouraged Lilly to promote its schizophrenia drug Zyprexa for a use not approved by regulators.[...]
